[1] 史大伟, 刘玲, 赵萌萌, 等. 肺炎支原体肺炎患儿支气管肺泡灌洗液中肺炎支原体耐药基因和13种病原检测结果分析[J]. 中华实用儿科临床杂志, 2022, 37(12):893-896. [2] CHEN J, QI X, YIN Y, et al.Effects of minocycline on macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a single-center retrospective study[J]. Transl Pediatr, 2021, 10(11):2997-3004. [3] BAE E, KIM Y J, KANG H M, et al.Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy[J]. Antibiotics (Basel), 2022, 11(9):1233 [4] 王秀芳, 李伟霞, 张艳丽,等. 儿童肺炎支原体坏死性肺炎预测指标研究[J]. 临床儿科杂志, 2019, 37(6):409-412. [5] 王瑞珠, 席艳丽, 郭斌, 等. 儿童肺炎支原体感染致坏死性肺炎的影像特点及血CG反应蛋白,DG二聚体的评价[J]. 实用放射学杂志, 2019, 35(6):952-955,962. [6] 曾洪武, 黄文献, 陈杰华, 等. 儿童坏死性肺炎的临床特点及胸部HRCT特征[J]. 放射学实践, 2018, 33(7):758-761. [7] 刘帅帅, 马静, 张忠晓, 等. 增强CT对儿童坏死性肺炎的诊断价值[J]. 中华实用儿科临床杂志, 2021, 36(4):267-270. [8] 国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 传染病信息, 2023, 36(4):291-297. [9] 吴琰, 魏会平, 曹欣, 等. 儿童下呼吸道肺炎支原体感染流行特点分析[J/CD]. 新发传染病电子杂志, 2021, 6(4):336-338. [10] DIAZ MH, BENITEZ AJ, WINCHELL JM.Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013[J]. J Clin Microbiol, 2015, 53(1):124-130. [11] 宣传司. 国家卫生健康委员会 2023 年 11 月 13 日新闻发布会文字实[EB/OL].(2023-11-13)[2023-12-17]. http://www.nhc.gov.cn/xcs/s3574/202311/0807e750e6cc4a81a22b6d881913cf5d.shtml. [12] 周云连, 刘金荣, 易秋维, 等. 儿童坏死性肺炎病原学的多中心回顾性研究[J]. 中华儿科杂志, 2021, 59(8):658-664. [13] HSIEH YC, HSUEH PR, LU CY, et al.Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan[J]. Clin Infect Dis, 2004, 38(6):830-835. [14] SEO H, CHA SI, SHIN KM, et al.Focal necrotizing pneumonia is a distinct entity from lung abscess[J]. Respirology, 2013, 18(7):1095-1100. [15] 陆权, 车大钿. 肺炎支原体性胸腔积液[J]. 中国实用儿科杂志, 2008, 23(4):241-244. [16] 黄倩, 曾赛珍, 陈玲玲, 等. 36例儿童坏死性肺炎临床特征分析[J]. 中国小儿急救医学, 2023, 30(2):115-121. [17] SPENCER DA, THOMAS MF.Necrotising pneumonia in children[J]. Paediatr Respir Rev, 2014, 15(3):240-245. [18] ZHENG Y, HUA L, ZHAO Q, et al.The Level of D-Dimer Is Positively Correlated With the Severity of Mycoplasma pneumoniae Pneumonia in Children[J]. Front Cell Infect Microbiol, 2021, 11:687391. [19] FOX JC, SZYJKOWSKI RS, SANDERSON SO, et al.Progressive cholestatic liver disease associated with clarithromycin treatment[J]. J Clin Pharmacol, 2002, 42(6):676-680. [20] KIM KW, SUNG JJ, TCHAH H, et al.Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study[J]. Korean J Pediatr, 2015, 58(6): 211-217. [21] ZHOU J, HE Z, MA S, et al.AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer[J]. Cancer Med, 2020, 9(15):5672-5677. [22] 李洪娜, 郭艳霞, 谢金霞, 等. 肺炎支原体肺炎患儿血清ALT、AST水平变化及其对预后的预测价值[J]. 山东医药, 2023, 63(23):55-57. [23] JIN X, ZHU Y, ZHANG Y, et al.Assessment of levels of D-dimer and interferon-γ in pediatric patients with Mycoplasma pneumoniae pneumonia and its clinical implication[J]. Exp Ther Med, 2018, 16(6):5025-5030. |